Move brings together AstraZeneca and Alexion colleagues in a purpose-built facility in Kendall Square, Cambridge, MA, a world-leading life sciences hub
Sumitomo Chemical began its nucleic acid drug substance contract manufacturing business in 2013
This study will enrol 210 ALS patients and study doses of 50 mg and 75 mg Usnoflast versus placebo
New research labs and process development services to enable next generation therapeutics
This includes $2 billion of new investment creating more than a thousand new, high-skilled jobs
Financing includes new funding from leading global organizations Eli Lilly and Company and EDBI
Acquisition encompasses a portfolio of RLT programs across a range of solid tumor indications
Lunaphore's flagship COMET technology is the only fully-automated, high-throughput, hyperplex platform with superior tissue profiling capabilities
According to Sun Pharma, the purpose of the strategic investment is to obtain access to the technology for certain compounds and territories while also fostering the development of novel pharmaceutical delivery systems.
Covaris is a global leader in the development and deployment of end-to-end solutions for high-throughput genomic and proteomic analysis
Subscribe To Our Newsletter & Stay Updated
